SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ — WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series “Collaborations That Transform,” highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary webinar, to be broadcast worldwide on July 16, will convene leading physicians, drug developers, patients and advocates. These experts will discuss the latest advances in the development of transformative medicines for hemophilia, including gene therapy and next generation technologies.
As an enabler of the biotech and medical device industry, WuXi AppTec shares the conviction that we must work collaboratively to solve industry-wide problems and bring transformational medicines to people living with rare diseases. On July 16, the webinar will continue the dynamic discussions that began with WuXi AppTec’s inaugural rare disease webinar in May. It is complimentary and open to the public.
WuXi AppTec welcomes all to join the conversation.
AGENDA (Eastern Daylight Time).
10:30 Welcome
10:35 – 11:00 Addressing the Unknowns in an Era of Transformations
11:00 – 12:00 The Quest for Transformative Medicines
12:00 Closing
View original content:http://www.prnewswire.com/news-releases/wuxi-apptec-to-launch-a-special-webinar-on-collaborations-that-transform-on-july-16–advances-in-rare-diseases-hemophilia-301090734.html
SOURCE WuXi AppTec
GE HealthCare to exclusively distribute nCommand Lite by IONIC Health for multi-vendor, multi-modality remote operations…
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for…
PLEASANTON, Calif.--(BUSINESS WIRE)--#Ophthalmology--RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA…
Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and…
London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…
MAULDIN, SC / ACCESSWIRE / March 25, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that…